- Multidrug-resistant Tuberculosis Spondylitis: A Case Report
-
Ki SC, Kim KS, Kim YH, Choi YS
- KMID: 2097839
- J Korean Soc Spine Surg.
- 2008 Jun;15(2):102-105.
- doi: 10.4184/jkss.2008.15.2.102
Multidrug-resistant tuberculosis, resistant to at least isoniazid and rifampicin, continues to present a serious challenge to human health. However, there are no reports addressing multidrug-resistant tuberculous spondylitis in Korea. We... -
- CITED
-
- Close
- SHARE
-
- Close
- The survey for clinical course of intractable pulmonary tuberculosis
-
Shim JJ
- KMID: 2081164
- Korean J Med.
- 2005 Dec;69(6):579-580.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Multidrug-resistant Tuberculosis
-
Hong YP
- KMID: 2349216
- J Korean Med Assoc.
- 1998 May;41(5):529-534.
- doi: 10.5124/jkma.1998.41.5.529
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors for Primary Multidrug Resistant Tuberculosis
-
Min J, Park K, Whang S, Kim J
- KMID: 2318744
- Tuberc Respir Dis.
- 2005 Dec;59(6):600-605.
BACKGROUND: Primary multidrug-resistant tuberculosis is defined as Mycobacterium tuberculosis isolates that are resistant to at least isoniazid and rifampin in never-been-treated tuberculosis patients, and this malady is caused by... -
- CITED
-
- Close
- SHARE
-
- Close
- Medical Management of Drug-Resistant Tuberculosis
-
Jeon D
- KMID: 2320639
- Tuberc Respir Dis.
- 2015 Jul;78(3):168-174.
- doi: 10.4046/trd.2015.78.3.168
Drug-resistant tuberculosis (TB) is still a major threat worldwide. However, recent scientific advances in diagnostic and therapeutic tools have improved the management of drug-resistant TB. The development of rapid molecular... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment for Multi-drug Resistant Tuberculosis
-
Ahn CM
- KMID: 2050139
- Tuberc Respir Dis.
- 1999 Jun;46(6):757-766.
- doi: 10.4046/trd.1999.46.6.757
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Concurrent, Prolonged Use of Bedaquiline and Delamanid for Multidrug-Resistant Tuberculosis
-
Hyun DG, Lee SH, Jo KW, Shim TS
- KMID: 2449428
- Korean J Med.
- 2019 Jun;94(3):294-298.
- doi: 10.3904/kjm.2019.94.3.294
Bedaquiline and delamanid were recently approved for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Korea. A treatment duration of 24 weeks was established based on phase 2 clinical trial data,... -
- CITED
-
- Close
- SHARE
-
- Close
- Fluoroquinolone resistance in multidrug-resistant tuberculosis patients
-
Lee HW, Yim JJ
- KMID: 2441007
- Korean J Intern Med.
- 2019 Mar;34(2):286-287.
- doi: 10.3904/kjim.2019.045
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pediatric tuberculosis and drug resistance
-
Kim YJ
- KMID: 2281455
- Korean J Pediatr.
- 2009 May;52(5):529-537.
- doi: 10.3345/kjp.2009.52.5.529
Drug-resistant tuberculosis in children has important implications for both the patients and tuberculosis control programs. In Korea, among all new patients, the isoniazid resistance rate was 9.9% and multidrug-resistant tuberculosis... -
- CITED
-
- Close
- SHARE
-
- Close
- WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea
-
Jeon D
- KMID: 2420575
- Tuberc Respir Dis.
- 2017 Oct;80(4):336-343.
- doi: 10.4046/trd.2017.0049
Despite progress made in tuberculosis control worldwide, the disease burden and treatment outcome of multidrug-resistant tuberculosis (MDR-TB) patients have remained virtually unchanged. In 2016, the World Health Organization released new... -
- CITED
-
- Close
- SHARE
-
- Close
- Issues Related to the Updated 2014 Korean Guidelines for Tuberculosis
-
Park JS
- KMID: 2320749
- Tuberc Respir Dis.
- 2016 Jan;79(1):1-4.
- doi: 10.4046/trd.2016.79.1.1
Tuberculosis (TB) remains a major public health problem in South Korea. The Joint Committee for the Development of Korean Guidelines for Tuberculosis published the Korean Guidelines for Tuberculosis in 2011... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of drug-resistant tuberculosis and its treatment
-
Yim JJ
- KMID: 2258566
- Korean J Med.
- 2009 Aug;77(2):152-156.
Drug-resistant tuberculosis (TB), especially multidrug-resistant (MDR)-TB and extensively drug resistant (XDR)-TB, poses a serious threat to global health because it requires treatment for a long duration and frequent hospitalization, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
-
Shim TS, Jo KW
- KMID: 2170440
- Infect Chemother.
- 2013 Dec;45(4):367-374.
- doi: 10.3947/ic.2013.45.4.367
Treatment of multidrug-resistant tuberculosis (MDR-TB) is challenging because of the high toxicity of second-line drugs and the longer treatment duration required compared with drug-susceptible TB. The efficacy of treatment for... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Disseminated Multidrug-Resistant Tuberculosis involving the Brain
-
Jung EK, Chang JY, Lee YP, Chung MK, Seo EK, Koo HS, Choi HJ
- KMID: 2170516
- Infect Chemother.
- 2016 Mar;48(1):41-46.
- doi: 10.3947/ic.2016.48.1.41
We report a case of a 23-year-old female immigrant from China who was diagnosed with multidrug-resistant tuberculosis affecting her lung and brain, resistant to the standard first-line therapeutics and streptomycin.... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug Resistance Patterns of Multidrug- and Extensively Drug-Resistant Tuberculosis in Korea: Amplification of Resistance to Oral Second-line Drugs
-
Kim CK, Shin SY, Kim HJ, Lee K
- KMID: 2376789
- Ann Lab Med.
- 2017 Jul;37(4):323-326.
- doi: 10.3343/alm.2017.37.4.323
We aimed to analyze the drug resistance patterns of multidrug-resistant and extensively drug-resistant tuberculosis (TB) and the difference of drug resistance among various settings for health care in Korea. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Multidrug-resistant Pulmonary Tuberculosis Among Young Korean Soldiers in a Communal Setting
-
Lee SW, Jeon K, Kim KH, Min KH
- KMID: 1779189
- J Korean Med Sci.
- 2009 Aug;24(4):592-595.
- doi: 10.3346/jkms.2009.24.4.592
The goal of this study was to evaluate the prevalence of first-line anti-tuberculosis drug resistance and risk factors associated with multidrug-resistant tuberculosis (MDR TB) among young soldiers in the Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Direct Detection of Rifampin-Resistant Mycobacterium Tuberculosis by Polymerase Chain Reaction and Line Probe Assay in Sputums
-
Lee MA
- KMID: 1863293
- Korean J Clin Pathol.
- 1998 Mar;18(1):71-76.
BACKGROUND: Recently, the control of tuberculosis may be threatened by widespread emergence of multidrug-resistant tuberculosis. Rifampin resistance is considered as a useful marker of multidrug-resistant tuberculosis and is developed by... -
- CITED
-
- Close
- SHARE
-
- Close
- Multidrug-resistant Tuberculosis
-
Yim JJ
- KMID: 2137819
- J Korean Med Assoc.
- 2006 Sep;49(9):790-798.
- doi: 10.5124/jkma.2006.49.9.790
Multidrug-resistant tuberculosis (MDR-TB), resistant to at least both isoniazid and rifampicin, poses a serious threat to global health because it requires treatment for a long duration and frequent hospitalization, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of RNA/RNA Duplex, Base Pair-mismatch Assay and 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyl Tetrazolium Bromide (MTT) Assay for Rapid Detection of Rifampin-resistant Mycobacterium tuberculosis
-
Hong SK, Chang KH, Park YS, Cho JH, Kim HY, Song YC, Kim JM
- KMID: 1515429
- Infect Chemother.
- 2003 Feb;35(1):12-17.
BACKGROUND: Multidrug-resistant tuberculosis is an increasing concern for public health in many parts of the world. We have evaluated the specificity and sensitivity of the mismatch assay and 3- (4,5-dimethylthiazol-2-yl)-2,5-diphenyl... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and treatment of multidrug-resistant tuberculosis
-
Kang YA
- KMID: 2194831
- J Korean Med Assoc.
- 2014 Jan;57(1):27-33.
- doi: 10.5124/jkma.2014.57.1.27
Multidrug-resistant tuberculosis (MDR-TB) is a great public health concern worldwide. MDR-TB denotes bacillary resistance to at least isoniazid and rifampicin. Extensively drug-resistant tuberculosis (XDR-TB) is MDR-TB with additional bacillary resistance... -
- CITED
-
- Close
- SHARE
-
- Close
